Finzati - Logo
PACS logo

PACS Group, Inc.

PACS • Medical - Care Facilities
$47.72
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$7.73B
Growth
44.5%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Positive revenue growth · 44.5%Positive free cash flow · 1.91Consistent free cash flow · 4/5High debt level · 3.38Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:37 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$47.72
Change0.00%
Shares Out161.99M
Market Cap$7.73B
Enterprise Value$7.81B
52W Range7.50 - 49.49
Beta-0.08
P/E28.72
P/S1.39
P/B6.96
P/FCF24.75
EV/Sales1.41

Investment DNA

How strong this company looks for long-term investors

64
out of 100
Business Quality
Margins, moat, returns
38/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
56/100
Why this score▼
Positive revenue growth · 44.5%Positive free cash flow · 1.91Consistent free cash flow · 4/5High debt level · 3.38Weak profitability

Analyst view

Analyst sentiment and price target

PACS
Analyst sentiment
Based on 8 analyst votes · 2026-10-20
100/100
Bullish
Bullish
8
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$48.00
Mean
$53.00
Median
$52.00
High
$60.00

Company Overview

IPO: 4/11/2024
Industry: Medical - Care Facilities
P/B i: 6.96
Debt / Equity i: 3.38
Operating Margin: 5.85%
Net Margin: 3.62%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 3.38
Current Ratio: 1.07
Quick Ratio: 1.07
Status: Good

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
Hancock Mark
Transaction: 07/15/2026
SELL
Change
-3,332
Price
$45.05
Filing
07/16/2026
Type
SELL
Jergensen Joshua
Transaction: 07/15/2026
SELL
Change
-233
Price
$45.76
Filing
07/16/2026
Type
SELL
Hancock Mark
Transaction: 07/14/2026
SELL
Change
-10,296
Price
$45.03
Filing
07/16/2026
Type
SELL